Hadi Al-Hasani

Hadi Al-Hasani serves as University Professor and Director of the Institute for Clinical Biochemistry and Pathobiochemistry at the German Diabetes Center (DDZ), affiliated with Heinrich Heine University Düsseldorf's Medical Faculty. He concurrently leads the Research Group Pathochemistry, focusing on molecular mechanisms of diabetes and metabolic disorders through biochemical and genetic approaches.

His primary research domains include Diabetes Pathogenesis, Insulin Signaling Pathways, and Metabolic Regulation, with specific expertise in Rab GTPase proteins (TBC1D1/TBC1D4), glucose transporter dynamics, and islet biology. Utilizing polygenic mouse models, his work bridges molecular biochemistry with clinical metabolic phenotypes to identify therapeutic targets for diabetes and obesity.

Analysis of his 2007-2018 publications reveals consistent innovation in diabetes mechanisms, particularly through comparative genomics of insulin secretion pathways and Rab-GAP protein functions. His research demonstrates progressive exploration from foundational GLUT4 trafficking studies (1998) to contemporary investigations of metabolic syndrome gene networks and tissue-specific insulin resistance.

Professor Al-Hasani's laboratory operates within the Pathochemistry Research Group at the Institute for Clinical Biochemistry and Pathobiochemistry, where his team integrates biochemical, genetic, and physiological methodologies to dissect molecular pathways underlying metabolic disease progression.